Prosecution Insights
Last updated: October 01, 2026

Wisconsin Alumni Research Foundation

Technology area: Biotechnology & Pharmaceuticals

102 pending office actions • 56 art units • 98 examiners • 0 of 102 (0%) have an AI response strategy ready • 124 patents granted in the last 365 days

Analysis

Wisconsin Alumni Research Foundation has 101 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 97 distinct examiners across 55 distinct art units. PAK, YONG D is the busiest examiner with 3 busiest examiner pending actions. The high number of 55 distinct art units relative to the 101 pending office actions indicates a very broad technical spread.

With 97 distinct examiners for the 101 pending office actions, almost every application is being reviewed by a different person. This variety in examiners means the foundation must navigate many different examination styles and technical standards across the 55 distinct art units. The 3 busiest examiner pending actions assigned to PAK, YONG D represent a small portion of the 101 pending office actions. Practitioners should coordinate across the 97 distinct examiners to ensure consistent prosecution outcomes.

The 55 distinct art units suggest that the portfolio touches on many specialized groups within the USPTO. Managing 101 pending office actions across these units requires an understanding of the specific technical standards applied by each group. Because the 97 distinct examiners are spread across 55 distinct art units, there is significant variety in the technical scrutiny applied to the applications. This structure requires a strategy that accounts for both individual examiner preferences and art unit trends.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

102
Total Pending OAs
73
Non-Final OAs
27
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 26 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

15
Overdue
0
Due this week
6
Due this month
3
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 26 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (15)Due ≤ 30 days (6)Due ≤ 60 days (3)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

52
Hard (51%)
37
Medium (36%)
13
Easy (13%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (1%)
§101 + other8 (8%)
§103 only27 (26%)
§102 only2 (2%)
§112 only10 (10%)
Double-patenting only3 (3%)
Double-patenting + other8 (8%)
Multi-statute (no §101)43 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

59
Life Sciences
58% of docket
3
Information Tech
3% of docket
1
Communications
1% of docket
9
Semiconductors
9% of docket
9
Mechanical / Eng
9% of docket
21
Business / Other
21% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,020 h
Manual time on pending OAs
204 h
Time saved (low, 20%)
357 h
Time saved (mid, 35%)
8.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAK, YONG D 3 74.6% +14.3%
SCHUBERG, LAURA J 2 23.6% +37.0%
GROOMS, TIFFANY NICOLE 2 57.8% +46.3%
WONG, EDNA 1 58.4% -19.7%
BOLER, RYNAE E 1 62.4% +8.8%
LUONG, DUY HAN 1 95.1% +7.7%
SCHERBEL, TODD J 1 76.2% +52.3%
KOWALKOWSKI, FIONA MARGARET 1 100.0% +0.0%
GEISEL, KARA E 1 75.1% +18.3%
SINCLAIR, DAVID M 1 68.4% +19.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18989456 Photonic Static Random Access Memory LUONG, DUY HAN —

Hard Cases (54)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18322861 LIGHT-EMITTERS WITH GROUP III-NITRIDE-BASED QUANTUM WELL ACTIVE REGIONS HAVING GAN INTERLAYERS KIM, JAY C 117d overdue
17833178 Ultrasound Probe Hand Shield ROZANSKI, MICHAEL T 91d overdue
18451658 METHOD TO ENRICH DESIRED TYPES IN SEED-DERIVED CROPS STOCKDALE, JESSICA NICOLE 73d overdue
17820488 RETINAL ORGANOID MODEL SYSTEMS HOLLAND, PAUL J 73d overdue
18231997 Clip on Torque Device for Endovascular Procedures WITTLIFF, KATERINA ANNA 28d overdue
17246219 SYSTEMS, METHODS, AND MEDIA FOR GENERATING AND USING SPIKING NEURAL NETWORKS WITH IMPROVED EFFICIENCY GODO, MORIAM MOSUNMOLA 1d overdue
18424697 STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY WESTERBERG, NISSA M 16d
18435421 Acoustic Subwavelength Imaging System ARMSTRONG, JONATHAN D 26d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18658840 YEAST STRAINS WITH SELECTED OR ALTERED MITOTYPES AND METHODS OF MAKING AND USING THE SAME GROOMS, TIFFANY NICOLE 51d overdue
19042945 IFNy AND TNFa CO-STIMULATION OF MESENCHYMAL STROMAL CELLS DERIVED FROM MINOR SALIVARY (LABIAL) GLANDS FOR THERAPEUTIC USE SCHUBERG, LAURA J —
18972024 TISSUE MANIPULATION AND CUTTING DEVICE AND RELATED METHODS SCHERBEL, TODD J —
18947889 Inverse Backscatter Absorption Gas Imaging GEISEL, KARA E —
18910720 AMPLIFICATION OF INTERFACIAL CAPACITANCE IN IONIC LIQUID ELECTROLYTES SINCLAIR, DAVID M —
18891498 MICROORGANISMS AND METHODS FOR PRODUCING CIS,CIS-MUCONIC ACID PAK, YONG D —
18819158 Generating Vasculogenic Cell Populations SCHUBERG, LAURA J —
18737647 RECOMBINANT MICROORGANISMS THAT CATABOLIZE LIGNIN AROMATICS AND METHODS OF USING SAME PAK, YONG D —

Top Art Units

Art UnitApps
1653 6
1631 5
1652 3
1637 3
1797 3
1795 2
1662 2
2488 2
2852 2
1633 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19396967 ELECTROCHEMICAL DEHYDROGENATION WONG, EDNA 1795 §103 Non-Final OA — Pending Nov 21, 2025
19244762 Otoscope Providing Low Obstruction Electronic Display BOLER, RYNAE E 3773 §103§112 Non-Final OA — Pending Jun 20, 2025
19042945 IFNy AND TNFa CO-STIMULATION OF MESENCHYMAL STROMAL CELLS DERIVED FROM MINOR SALIVARY (LABIAL) GLANDS FOR THERAPEUTIC USE SCHUBERG, LAURA J — §103 Non-Final OA — Pending Jan 31, 2025
18989456 Photonic Static Random Access Memory LUONG, DUY HAN 2825 §112 Non-Final OA — Pending Dec 20, 2024
18972024 TISSUE MANIPULATION AND CUTTING DEVICE AND RELATED METHODS SCHERBEL, TODD J 3771 §102§103§112 Non-Final OA — Pending Dec 06, 2024
18955228 Localizing Ion-Channel Activation Using Nullifying Waveforms KOWALKOWSKI, FIONA MARGARET 3792 §102§103§112 Non-Final OA — Pending Nov 21, 2024
18947889 Inverse Backscatter Absorption Gas Imaging GEISEL, KARA E 2877 §102§103 Non-Final OA — Pending Nov 14, 2024
18910720 AMPLIFICATION OF INTERFACIAL CAPACITANCE IN IONIC LIQUID ELECTROLYTES SINCLAIR, DAVID M 2847 §102§103 Non-Final OA — Pending Oct 09, 2024
18906694 DEREGULATED DHS AND TYRA ENZYMES OF GRASSES ENABLE EFFICIENT PRODUCTION OF BOTH TYROSINE AND PHENYLALANINE STANKOVIC, BRATISLAV 1662 §102§112DP Non-Final OA — Pending Oct 04, 2024
18900566 Gas Phase Sample Preparation for Cryo-Electron Microscopy IPPOLITO, NICOLE MARIE — DP Non-Final OA — Pending Sep 27, 2024
18891498 MICROORGANISMS AND METHODS FOR PRODUCING CIS,CIS-MUCONIC ACID PAK, YONG D — §102§103§112 Non-Final OA — Pending Sep 20, 2024
18829184 Methods for In Vivo Tracking of Cells MOSHER, ERIC PARKER — §103§112 Non-Final OA — Pending Sep 09, 2024
18819158 Generating Vasculogenic Cell Populations SCHUBERG, LAURA J — §103§112DP Non-Final OA — Pending Aug 29, 2024
18790293 HEMOGLOBIN-BASED NANOPARTICLES PEEBLES, KATHERINE — §102§112 Non-Final OA — Pending Jul 31, 2024
18755293 SYSTEMS, METHODS, AND MEDIA FOR CONCURRENT DEPTH AND MOTION ESTIMATION USING INDIRECT TIME OF FLIGHT IMAGING XU, XIAOLAN 2488 §103 Non-Final OA 41d Pending Jun 26, 2024
18743376 MICROORGANISMS AND METHODS FOR PRODUCING REUTERIN SAIDHA, TEKCHAND 1652 §112Other Non-Final OA — Pending Jun 14, 2024
18737647 RECOMBINANT MICROORGANISMS THAT CATABOLIZE LIGNIN AROMATICS AND METHODS OF USING SAME PAK, YONG D 1652 §103§112 Non-Final OA — Pending Jun 07, 2024
18714481 DEVELOPMENT OF FOOD-GRADE FUNGAL FERMENTATES WITH ANTIMICROBIAL ACTIVITY AND THE USE THEREOF AFREMOVA, VERA 1653 §102§103 Non-Final OA — Pending May 29, 2024
18672924 MICROBES AND METHODS FOR SELECTIVE DETOXIFICATION OF LIGNOCELLULOSIC BIOMASS PAK, YONG D 1652 §102§103§112 Non-Final OA — Pending May 23, 2024
18670878 Soil Moisture Sensor BOLDUC, DAVID J 2852 §102§103§112 Final Rejection — Pending May 22, 2024
18665208 SOLVENT-BASED PLASTIC RECYCLING METHOD TO REMOVE INKS AND PRODUCE CLEAR FILMS RIETH, STEPHEN EDWARD — §102§103§112 Non-Final OA — Pending May 15, 2024
18664936 Microfluidic Device For Profiling Biochemical Samples HERBERT, MADISON TAYLOR — §102§103§112 Non-Final OA — Pending May 15, 2024
18658840 YEAST STRAINS WITH SELECTED OR ALTERED MITOTYPES AND METHODS OF MAKING AND USING THE SAME GROOMS, TIFFANY NICOLE 1637 §103 Final Rejection 51d overdue Pending May 08, 2024
18708496 MUTANT ACE2 PROTEINS AND METHODS OF USING SAME EIX, EMILY FAY 1653 §102§103§112 Non-Final OA — Pending May 08, 2024
18658147 Camera Sensor with Shared Pixel Weighting WENG, PEI YONG — §103 Non-Final OA — Pending May 08, 2024
18657155 STRAIN-RELAXED PSEUDO-SUBSTRATES AND METHODS OF MAKING SAME USING THERMAL POROSIFICATION RAHMAN, MOHAMMAD A — §102§112 Non-Final OA — Pending May 07, 2024
18650408 Modular, Multi-Axis Force Sensor for Measuring Joint Contact Forces WALSH, RYAN D 2852 §102§103 Final Rejection — Pending Apr 30, 2024
18629296 VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME SHOMER, ISAAC 1612 §103§112 Non-Final OA — Pending Apr 08, 2024
18626102 AUTOXIDATION CATALYSIS FOR CARBON CARBON BOND CLEAVAGE IN LIGNIN BAKSHI, PANCHAM — §103§112DP Non-Final OA — Pending Apr 03, 2024
18623989 GENERALIZED EVENT CAMERA DHILLON, PUNEET S 2488 §103 Non-Final OA 86d overdue Pending Apr 01, 2024
18694831 MATRICES AND SYSTEMS FOR PRESERVATION OF BIOMOLECULES IN VACUUM MCGUIRK, JOHN SCHUYLER — §102§103§112 Non-Final OA — Pending Mar 22, 2024
18612463 HIGH THROUGHPUT NEWBORN SCREENING ASSAY FOR ANGELMAN AND PRADER-WILLI SYNDROMES BROWN, MINDY G — §101§103§112 Non-Final OA — Pending Mar 21, 2024
18613041 REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION TAKENAKA, RISA 1653 §102§103§112 Non-Final OA — Pending Mar 21, 2024
18611181 TWO COMBINED MUTATIONS THAT INTRODUCE THE SECOND ENTRY PATHWAY TO SYNTHESIZED LIGNIN FROM TYROSINE IN PLANTS BOWERS, ERIN M 1653 §112 Non-Final OA — Pending Mar 20, 2024
18596069 GRAVITY SURVEYS ON AN UNSTAFFED AERIAL VEHICLE BHAT, ADITYA S 2855 §101§103 Non-Final OA — Pending Mar 05, 2024
18596320 METHODS OF INDUCING CARDIAC CELL PROLIFERATION AND INDUCING HEART REGENERATION ALSOMAIRY, SARAH ABDOALATIF — §102§103§112 Non-Final OA — Pending Mar 05, 2024
18440260 EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS LARA, CAROLINE MONSERRAT 1633 §102§112DP Non-Final OA — Pending Feb 13, 2024
18439978 METHODS OF FORMING SYNTACTIC FOAMS USING SELECTIVE LASER SINTERING SANDERS, JAMES M 1743 §103 Final Rejection — Pending Feb 13, 2024
18435421 Acoustic Subwavelength Imaging System ARMSTRONG, JONATHAN D 3645 §102§103 Non-Final OA 26d Pending Feb 07, 2024
18434662 LIPOPEPTIDES, NANOPARTICLES AND METHODS OF USE KWON, JOHN SEUNGJAI — §102§103 Non-Final OA — Pending Feb 06, 2024
18426920 SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM OTTON, ALICIA L 1699 §102 Non-Final OA — Pending Jan 30, 2024
18424697 STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY WESTERBERG, NISSA M 1618 §103§112Other Non-Final OA 16d Pending Jan 26, 2024
18417305 SYNTHETIC YEAST CELLS AND METHODS OF MAKING AND USING THE SAME RYAN, DOUGLAS CHARLES 1635 §112 Final Rejection 127d overdue Pending Jan 19, 2024
18396865 ELECTROCHEMICAL LITHIUM EXTRACTION AND RECOVERY PARENT, ALEXANDER RENE 1795 §103 Final Rejection — Pending Dec 27, 2023
18540517 BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION SALMON, KATHERINE D 1682 §112 Final Rejection 71d overdue Pending Dec 14, 2023
18532418 METAL COMPOUND BASED CATALYSTS FOR ELECTROSYNTHESIS OF HYDROGEN PEROXIDE AND LINEAR PAIRED ELECTROCHEMICAL VALORIZATION OF BIOMASS-DERIVED FEEDSTOCKS MENDEZ, ZULMARIAM — §102§103§112 Non-Final OA — Pending Dec 07, 2023
18565772 OXYGEN ION TRANSPORT MATERIALS AND RELATED DEVICES DAVIS, SHENG HAN 1732 §103 Non-Final OA — Pending Nov 30, 2023
18518234 Diazobutanone Linker - Assisted High-Throughput Quantitative Analysis for Phosphate and Sulfate Containing Lipids RHOADES, DEREK JAMES 1797 §112 Non-Final OA — Pending Nov 22, 2023
18516561 SYNTHETIC IL6-IL1BETA FUSION CYTOKINE FOR PROMOTING T CELL CYTOTOXIC FUNCTION, T CELL PROLIFERATION, AND TUMORICIDAL ACTIVITY ABBAS, SYED JARAR — §103§112 Non-Final OA — Pending Nov 21, 2023
18516385 HOST FACTORS THAT ENHANCE VIRAL PRODUCTION VIA VIRALLY DRIVEN FITNESS-BASED CRISPR SCREENING YU, DAVID TUYANG 4100 §112 Non-Final OA — Pending Nov 21, 2023
18508825 GENETICALLY ENCODED SYNTHETIC REACTION-DIFFUSION SYSTEM THAT CAN GENERATE PROGRAMMABLE OSCILLATIONS, PATTERNS, AND SPATIOTEMPORAL SIGNALING CIRCUITS IN MAMMALIAN CELLS ARMATO JR, DENNIS IGNATIUS 1651 §102§103 Non-Final OA — Pending Nov 14, 2023
18556737 ANALYSIS OF FRAGMENT ENDS IN DNA WOITACH, JOSEPH T — §101§103 Non-Final OA — Pending Oct 23, 2023
18381855 Ferroelectric Separators for Suppressing Dendrites Growth in Rechargeable Batteries CLEVELAND, TIMOTHY C 1774 §103§112 Non-Final OA — Pending Oct 19, 2023
18379435 Microscope Enabled 3D Bioprinting System WOO, JONATHAN BRIAN 1700 §103 Final Rejection — Pending Oct 12, 2023
18373418 COMPOSITIONS AND METHODS FOR IMPROVING CARDIAC STRUCTURE AND/OR FUNCTION SZNAIDMAN, MARCOS L 1628 §101Other Non-Final OA — Pending Sep 27, 2023
18471452 BIOMIMETIC CATALYSTS FOR DIVERSE INDUSTRIAL APPLICATIONS IN CHEMICAL REACTIONS LEAVITT, MORDECAI MIZANI 1742 §102§103 Non-Final OA — Pending Sep 21, 2023
18471461 IDENTIFYING DISEASE-CAUSING HUMAN DDX41 GENETIC VARIANTS SITTON, JEHANNE SOUAYA 1682 §112DP Final Rejection — Pending Sep 21, 2023
18370296 METHODS OF PREDICTING RESPONSES TO DISEASE TREATMENTS NEGIN, RUSSELL SCOTT — §101§112 Non-Final OA — Pending Sep 19, 2023
18243833 Biological Age and Survival Risk Determination from Imaging Biomarkers ELLIOTT, JORDAN MCKENZIE 2666 §103 Non-Final OA — Pending Sep 08, 2023
18451617 GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS GONZALES, JOSEPHINE MARIA 1631 §103 Non-Final OA — Pending Aug 17, 2023
18451658 METHOD TO ENRICH DESIRED TYPES IN SEED-DERIVED CROPS STOCKDALE, JESSICA NICOLE 1663 §103§112 Non-Final OA 73d overdue Pending Aug 17, 2023
18451614 NONIONIC, REDOX-CLEAVABLE SURFACTANT FOR MASS SPECTROMETRY-BASED PROTEOMICS AND STRUCTURAL BIOLOGICAL APPLICATIONS XU, XIAOYUN 1797 §102 Non-Final OA — Pending Aug 17, 2023
18231997 Clip on Torque Device for Endovascular Procedures WITTLIFF, KATERINA ANNA 3783 §102§103 Final Rejection 28d overdue Pending Aug 09, 2023
18228202 Integrated Design Optimization and Material and Subassembly Selection using Machine Learning HANN, JAY B — §102§103§112 Non-Final OA — Pending Jul 31, 2023
18261267 FREEZING AND JACKETING GAS-PHASE BIOMOLECULES WITH AMORPHOUS ICE FOR ELECTRON MICROSCOPY BOWERS, NATHAN ANDREW 1799 DP Non-Final OA 43d overdue Pending Jul 13, 2023
18351246 Macrophage Cell Therapy to Treat Orthopedic Injury WEHBE, ANNE MARIE SABRINA 1634 §112 Non-Final OA — Pending Jul 12, 2023
18218325 METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION KIFLE, BRUCK 1624 §112DPOther Non-Final OA 61d Pending Jul 05, 2023
18345385 Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination CANELLA, KAREN A 1643 DP Non-Final OA — Pending Jun 30, 2023
18256805 REGULATORY ELEMENTS FOR SCHWANN CELL-SPECIFIC GENE EXPRESSION GIBBS, TERRA C 1635 §102§103§112 Final Rejection 27d Pending Jun 09, 2023
18332457 Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity STOICA, ELLY GERALD 1618 §103§112DP Non-Final OA — Pending Jun 09, 2023
18255609 POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION SAOUD, CHRISTINE J 1645 §101§112 Non-Final OA — Pending Jun 02, 2023
18327714 Bead-Enabled, Efficient, and Rapid Multi-Omic Sample Preparation for Mass Spectrometry Analysis KOROTCHKINA, LIOUBOV G 1797 §103§112 Non-Final OA — Pending Jun 01, 2023
18323912 MICROBES WITH REDUCED ADHESION CHARACTERISTICS UNDERDAHL, THANE E 1699 §103§112 Final Rejection — Pending May 25, 2023
18322861 LIGHT-EMITTERS WITH GROUP III-NITRIDE-BASED QUANTUM WELL ACTIVE REGIONS HAVING GAN INTERLAYERS KIM, JAY C 2815 §103§112 Final Rejection 117d overdue Pending May 24, 2023
18200869 Non-Cavitational Mechanical Pulsed Ultrasound Therapy FRITH, SEAN A 3798 §103 Final Rejection 16d Pending May 23, 2023
18308386 HIGH-FREQUENCY GROUP III-NITRIDE-BASED HIGH ELECTRON MOBILITY TRANSISTORS WITH HIGH-ALUMINUM CONCENTRATION BARRIERS AND RECESSED GATES HRNJIC, ADIN 2817 §103 Non-Final OA — Pending Apr 27, 2023
18302636 COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS MELCHIOR, JAMES RYLAND 1644 §103§112 Non-Final OA 84d Pending Apr 18, 2023
18189056 COMBINATORIAL PLATFORM FOR HIGH-THROUGHPUT POLYNUCLEOTIDE-ENCODED CATALYST DISCOVERY GROSS, CHRISTOPHER M 1684 §103 Final Rejection — Pending Mar 23, 2023
18245868 IDENTIFICATION OF SARS-COV-2 EPITOPES DISCRIMINATING COVID-19 INFECTION FROM CONTROL AND METHODS OF USE GAO, ASHLEY HARTMAN 1600 §103§112 Non-Final OA — Pending Mar 17, 2023
18183466 ALLOY AND COMPOSITE FORMATION BY REACTIVE SYNTHESIS DURING ADDITIVE MANUFACTURING KESSLER, CHRISTOPHER S 1759 §103 Final Rejection 30d Pending Mar 14, 2023
18178205 Surface Hydration with an Ion Beam LOGIE, MICHAEL J 2881 §102§103§112 Non-Final OA 54d Pending Mar 03, 2023
18173535 BROADLY PROTECTIVE INFLUENZA B VIRUS VACCINES FOLEY, SHANON A 1671 §101§102§112 Non-Final OA — Pending Feb 23, 2023
18165244 SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof PHILIPOSE, HANNAH SARAH 1631 §103§112 Non-Final OA — Pending Feb 06, 2023
18058419 RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS GROOMS, TIFFANY NICOLE 1637 §103 Final Rejection — Pending Nov 23, 2022
17926804 EPIGENETIC MODIFICATION OF SELECT GENES AS MARKERS OF HYPERSOMNOLENCE KAPUSHOC, STEPHEN THOMAS 1683 §103 Final Rejection 52d overdue Pending Nov 21, 2022
17926113 MULTI-FUNCTIONAL GSH-RESPONSIVE SILICA NANOPARTICLES FOR DELIVERY OF BIOMOLECULES INTO PLANT CELLS BOYKIN, TERRESSA M 1662 §103Other Non-Final OA — Pending Nov 17, 2022
17980883 METHODS OF GENOME EDITING INCLUDING CONTROLLED OPENING OF CHROMATIN ALLEN, SARAH ELIZABETH 1637 §103 Final Rejection — Pending Nov 04, 2022
17973020 Simplified Compositions and Methods for Generating Neural Stem Cells from Human Pluripotent Stem Cells DUTT, ADITI 1675 §112DP Non-Final OA — Pending Oct 25, 2022
17911367 KIR 7.1 GENE THERAPY VECTORS AND METHODS OF USING THE SAME SIFFORD, JEFFREY MARK 1671 §112 Final Rejection 74d overdue Pending Sep 13, 2022
17820488 RETINAL ORGANOID MODEL SYSTEMS HOLLAND, PAUL J 1656 §101§103 Final Rejection 73d overdue Pending Aug 17, 2022
17863363 LPS Priming of Stromal Cells to Generate LPS-Specific Exosome Educated Macrophages FOX, ALLISON M 1633 §112Other Final Rejection 37d overdue Pending Jul 12, 2022
17811640 Tissue Load Sensor with Reduced Calibration Requirements WARSI, YASMEEN S 3791 §101§112 Non-Final OA — Pending Jul 11, 2022
17833178 Ultrasound Probe Hand Shield ROZANSKI, MICHAEL T 3797 §102§103§112 Non-Final OA 91d overdue Pending Jun 06, 2022
17545416 METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES STAVROU, CONSTANTINA E 1632 §103 Non-Final OA — Pending Dec 08, 2021
17609064 WASHED PLATELET EXTRACT NGUYEN, NGHI V 1653 §103 Final Rejection — Pending Nov 05, 2021
17495597 MULTICELL CONJUGATES FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES ZHU, JIANJIAN 1631 §103 Final Rejection 35d overdue Pending Oct 06, 2021
17407606 NONVIRAL GENERATION OF GENOME EDITED CHIMERIC ANTIGEN RECEPTOR T CELLS SPENCER, ANDREA LYNNE MORRIS 1631 §103 Final Rejection — Pending Aug 20, 2021
17427180 DEVICES AND METHODS FOR MEASURING BRAIN STATE COOPER, JONATHAN EPHRAIM 3791 §103 Final Rejection 29d Pending Jul 30, 2021
17343647 COMPOSITIONS AND METHODS FOR PRECISE PATTERNING OF POSTERIOR NEUROECTODERM FROM HUMAN PLURIPOTENT STEM CELLS WILLIAMS, EMMALEE RAE 1653 §103 Final Rejection — Pending Jun 09, 2021
17323715 GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS ROGERS, ERIC JASON 1638 §102§103§112 Non-Final OA 53d Pending May 18, 2021
17246219 SYSTEMS, METHODS, AND MEDIA FOR GENERATING AND USING SPIKING NEURAL NETWORKS WITH IMPROVED EFFICIENCY GODO, MORIAM MOSUNMOLA 2148 §102§103 Non-Final OA 1d overdue Pending Apr 30, 2021
17117062 IN VITRO EXPANSION OF DOPAMINERGIC SUBTYPE NEURONAL PROGENITORS DERIVED FROM PLURIPOTENT STEM CELLS MIANO, JOSEPH PAUL 1631 §103 Non-Final OA — Pending Dec 09, 2020

Managing Wisconsin Alumni Research Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month